Patterns and Predictors of Red Blood Cell Transfusion in the Pediatric Intensive Care Unit: A Retrospective Cohort Study


AKBAŞLI İ. T., KESİCİ S., BAYRAKCİ B.

Nigerian Journal of Clinical Practice, cilt.29, sa.4, ss.401-408, 2026 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2026
  • Doi Numarası: 10.4103/njcp.njcp_786_25
  • Dergi Adı: Nigerian Journal of Clinical Practice
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE
  • Sayfa Sayıları: ss.401-408
  • Anahtar Kelimeler: Anemia, critically Ill children, individualized medicine, RBC transfusion, transfusion strategies
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/Aim: To evaluate red blood cell (RBC) transfusion practices in a pediatric intensive care unit (PICU) and identify factors predicting transfusion needs. Methods: A retrospective observational study was conducted on children (0–18 years) admitted to a tertiary academic PICU from January 2015 to December 2021. Demographic data, clinical parameters, and transfusion events were analyzed using Chi-square tests, logistic regression, and Kaplan-Meier estimation. Results: Of 2,011 patients, 27.7% (n = 558) received at least one RBC transfusion, with a median pre-transfusion hemoglobin level of 8.9 g/dL [IQR: 8.1–9.6]. Anemia was present in 47.59% (n = 957) at admission, with 48.17% (n = 461) requiring transfusion. Younger age (0–2 years: OR 2.22, 95% CI 1.9–2.61) and lower weight-for-age Z (WFA-Z) scores (severely underweight: OR 1.64, 95% CI 1.2–2.24) were associated with increased transfusion likelihood. Multiple transfusions were linked to higher mortality risk (OR 15.16, 95% CI 8.0–28.73, P < 0.001). Conclusion: Transfusion decisions in the PICU appeared to be influenced not only by hemoglobin values but also by age-related physiology, nutritional status, and baseline anemia. Anemia at discharge remained common, underscoring the need for structured post-discharge follow-up and prospective studies to refine individualized transfusion decision frameworks.